Reassessment of defibrase in treatment of acute cerebral infarction: A multicenter, randomized, double-blind, placebo-controlled trial

Chinese Medical Sciences Journal

Volumn 20, Issue 3, 2005, Pages 151-158

  Liu, Xiu Qin ^a  

^a NONE

Author keywords

Acute cerebral infarction; Defibrase; Fibrinogen

Indexed keywords

BATROXOBIN; PLACEBO;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STROKE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BATROXOBIN; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOGEN; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; QUALITY CONTROL; RECURRENCE;

EID: 26944477420     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
3. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145-50.
4. Cooperating Group for National 95' Project. Intravenous thrombolysis with urokinase for acute cerebral infarction. Chin J Neurol 2002;35:210-3.
5. Madhavan R, Jacobs BS, Levine SR. Stroke trials: what have we learned? Neurol Res 2002;24 Suppl 1:S27-32.
6. Elger B, Hornberger W, Schwarz M, et al. MRI study on delayed ancrod therapy of focal cerebral ischaemia in rats. Eur J Pharmacol 1997;336:7-14.
7. Feng JC, Yao ML, Wang XM, et al. Influence of homemade defibrase on infarct volume and behavior in rats after cerebral focal ischemia and reperfusion. J Apoplexy Nerv Dis 2002;3:134-6.
8. Wang HS, Wang XM, Yao ML, et al. Effect of defibrase on the apoptosis and ultrastructure of cerebrovascular endothelial cell after focal cerebral ischemia in rats. J Apoplexy Nerv Dis 2002;19:12-3.
9. Yin M, Huang RX, Xiao XH, et al. Mechanism of defibrase anti-ischemia reperfusion injury. Acad J Kunming Med Coll 2002;3:46-8.
10. Hossmann V, Heiss WD, Bewermeyer H, et al. Controlled trial of ancrod in ischemic stroke. Arch Neurol 1983;40:803-8.
11. Olinger CP, Brott TG, Barsan WG, et al. Use of ancrod in acute or progressing ischemic cerebral infarction. Ann Emerg Med 1998;17:1208-9.
12. The Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke 1994;25:1755-9.
13. Sherman DG, Atkinson RP, Chippendale T, et al. Intravenous ancrod for treatment of acute ischemic stroke. JAMA 2000;283:2395-403.
14. The Cooperative Group of Reassessment of Defibrase. Reassessment of defibrase in treatment of acute cerebral infarction. Chin J Neurol 2000;33:263-7.
15. Liu M, Zhang SH. New knowledge: Intention to treat analysis in clinical experiments. BMJ Chinese Edition 2001;4:223-4.
16. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.